Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...
Saint Francis Hospital will expand its prehospital whole blood program to a fourth EMS agency, with more than 250 field ...
HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing ...
Red blood cells are essential for oxygen transport and immune function in the human body. When these cells become abnormally shaped, they can indicate serious health conditions, including diabetes, ...
Kavita Mehta suffers from beta thalassaemia, a genetic condition preventing her body from producing sufficient haemoglobin ...
The organisation explains that O-negative blood serves as a universal donor type, making it the primary choice for critical ...
Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...
The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
2don MSN
FDA approves first oral drug for thalassemia anemia, offering new hope beyond blood transfusions
The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...
Scientists found that colour production in birds is not just cosmetic but may be part of the body’s internal defence system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback